How do we design, implement, and manage an ongoing program to provide iron supplements to women blood donors?

Transfusion

Volumn 54, Issue 11, 2014, Pages 2795-2801

  White, Linda K ^a   Harris, Vicki J ^a   Cruz, Julie L ^a   Waxman, Dan A ^a  

^a Indiana Blood Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IRON;

ARTICLE; BLEEDING DISORDER; BLOOD DONOR; CLINICAL PRACTICE; COMMUNITY CARE; COST BENEFIT ANALYSIS; DIET SUPPLEMENTATION; DONOR SELECTION; FEMALE; FOLLOW UP; FUNDING; GASTROINTESTINAL ABSORPTION; HEALTH CARE COST; HEALTH PROGRAM; HOMEOSTASIS; HUMAN; IRON FOR WOMEN PROGRAM; IRON INTAKE; IRON STORAGE; IRON THERAPY; MASS SCREENING; PHYSIOLOGIC MONITORING; POPULATION; PROCESS DESIGN; PROGRAM APPROPRIATENESS; DRUG EFFECTS; INTESTINE ABSORPTION; PHYSIOLOGY;

BLOOD DONORS; DIETARY SUPPLEMENTS; FEMALE; HUMANS; INTESTINAL ABSORPTION; IRON;

EID: 84912525818     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12803     Document Type: Article

References (14)

1. Huebers HA, Brittenham GM, Csiba E, et al. Absorption of carbonyl iron. J Lab Clin Med 1986; 108: 473-478.
2. Gordeuk VR, Brittenham GM, Hughes MA, et al. Carbonyl iron for short-term supplementation in female blood donors. Transfusion 1987; 27: 80-85.
3. Gordeuk VR, Brittenham GM, Bravo J, et al. Prevention of iron deficiency with carbonyl iron in female blood donors. Transfusion 1990; 30: 239-245.
4. Bianco C, Brittenham G, Gilcher RO, et al. Maintaining iron balance in women blood donors of childbearing age: summary of a workshop. Transfusion 2002; 42: 798-805.
5. Newman B,. Iron depletion by whole-blood donation harms menstruating females: the current whole-blood-collection paradigm needs to be changed. Transfusion 2006; 46: 1667-1681.
6. Cable RG, Glynn SA, Kiss JE, et al.; for the NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II). Iron deficiency in blood donors: the REDS-II Donor Iron Status Evaluation (RISE) Study. Transfusion 2012; 52: 702-711.
7. Bryant BJ, Yau YY, Arceo SM, et al. Iron replacement therapy in the routine management of blood donors. Transfusion 2012; 52: 1566-1575.
8. FDA Public Workshop. Hemoglobin standards and maintaining adequate iron stores in blood donors. November 8, 2011. [cited 2014 Jul 11]. Available from: http://www.fda.gov/downloads/BiologicsBloodVaccines/NewsEvents/WorkshopsMeetingsConferences/transcriptsminutes/UCM281477.pdf
9. Bryant BJ, Yau YY, Arceo JA, et al. Ascertainment of iron deficiency and depletion in blood donors through screening questions for pica and restless legs syndrome. Transfusion 2013; 53: 1637-1644.
10. Spencer BR, Kleinman S, Wright DJ, et al.; for the NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II) REDS-II Donor Iron Status Evaluation (RISE) Analysis Group. Restless legs syndrome, pica and iron status in blood donors. Transfusion 2013; 53: 1645-1652.
11. Truilzi DJ, Shoos KL,. AABB Association Bulletin #12-03. Strategies to monitor, limit, or prevent iron deficiency in blood donors. September 21, 2012 [cited 2014 Jul 11]. Available from: http://www.aabb.org
12. Centers for Disease Control and Prevention. Recommendations to prevent and control iron deficiency in the United States. MMWR Recomm Rep 1998 Apr 3;47 (RR-3): 1-36.
13. Raichart CL, Harris V, Cruz JL,. Overall efficiencies gained by implementing HemoCue Hb301. Transfusion 2010; 50 Suppl 2: 126A.
14. Raichart CL, White LK, Harris V, et al. Efficiencies gained for the Iron For Women program by implementing HemoCue Hb301. Transfusion 2010; 50 Suppl 2: 237A.